This study prospectively analyzed 43 patients with idiopathic normal pressure hydrocephalus (INPH) who were randomized to either a flow-regulated (FR) or differential pressure (DP) shunt valve. Both groups showed improvement on the Neuropsychological Assessment Battery (NAB) and Berg Balance Scale at 6 and 12 months post-operation compared to baseline. The FR group demonstrated more striking improvement at 6 months on the NAB and Berg Balance Scale. The DP group experienced a higher rate of subdural hematomas, most of which were managed with shunt reprogramming. Both valve types were effective in treating INPH, but the FR valve showed earlier improvement and fewer complications.
Questioning the Use of Epinephrine to Treat Cardiac ArrestEmergency Live
"The role of epinephrine drug therapy during cardiac arrest:A properly evaluation of this traditional therapy seems necessary"
Clifton W. Callaway, MD, PhD on JAMA, dec 2012
Questioning the Use of Epinephrine to Treat Cardiac ArrestEmergency Live
"The role of epinephrine drug therapy during cardiac arrest:A properly evaluation of this traditional therapy seems necessary"
Clifton W. Callaway, MD, PhD on JAMA, dec 2012
Pulse Wave Velocity: Theory, Applications, Methods, and Future DirectionsInsideScientific
Lee Stoner, PhD and Gabriel Zieff, MA present a complete, in-depth overview of their research involving Pulse Wave Velocity (PWV) in a variety of different applications and a deep dive into the methods they use to record high-quality, repeatable data.
Arguably, the “gold-standard” method for noninvasive assessment of cardiovascular disease risk is pulse wave velocity. The PWV is widely used in both epidemiological and physiological studies to assess arterial stiffness, a construct dependent on the functional and structural characteristics of a vessel. PWV is calculated by measuring the transit time of the arterial waveform between two points of a measured distance. The most widely studied path is between the carotid and femoral arteries, which represents the aorto-illiac pathway. Traditionally, these measurements are made using tonometers, which are highly sensitive pressure transducers. However, alternative approaches to tonometry are available, and pathways other than the aorta can be measured. These alternative approaches may be better suited for use with certain populations or study designs. The focus of the presentation is to assist the audience in identifying the correct research tool for their particular research paradigm. Specifically, these experts outline the theoretical principles underlying PWV, as well as the importance of this measure to both epidemiological and physiological studies. Subsequently, they highlight some of the different approaches for measuring PWV, including technical considerations. This is followed by discussion pertaining to the identification of the appropriate PWV measure for the specific study design and populations of interest. This includes consideration of internal and external validity. They end the session by providing some tips to facilitate high-quality PWV assessments.
Key Topics Include:
- Meaning and clinical importance of pulse wave velocity
- How to measure and interpret pulse wave velocity
- Considerations for internal- and external-validity
- Considerations for the measurement of pulse wave velocity of various study designs and populations
Pearls about NSAIDs and their usage in the managaement of chronic pain, considering safety profile of both selective cox-2 or non selective cox-2 inhibitors
The Role of Extracorporeal Photopheresis in Scleroderma is presented by
Jaehyuk Choi
Assistant Professor in the Department of Dermatology
Director of the Extracorporeal Photopherisis Unit
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...Dra. Mônica Lapa
Summary The recent development of treatment modalities for patients with
idiopathic pulmonary arterial hypertension has been based on the evaluation of
many different markers such as functional capacity, addressed by NYHA classification, six-minute walk test (6 MWT) and hemodynamic parameters. The aim of this
study was to evaluate the correlation of N-terminal fragment (NT-proBNP) with other
markers in IPAH and its potential for patient stratification.
We studied 42 IPAH patients consecutively evaluated through right heart
catheterization in the absence of any specific treatment for pulmonary hypertension. Blood samples, clinical evaluation and 6 MWF distance were collected at
baseline.
The levels of NT-proBNP showed a high correlation with hemodynamic
parameters, such as pulmonary vascular resistance (r ¼ 0:80, Po0.001). A significant
difference was found among patients with different functional classes, addressed by
NYHA classification (Po 0.02 for all groups comparison). The discriminant analysis
reinforced the ability of NT-proBNP to stratify patients according to NYHA functional
class. Compared to the other variables studied (hemodynamics and 6 MWT), NTproBNP had the lowest level of overlap in the stratification of IPAH patients.
We conclude that NT-proBNP differs among the different functional classes and
correlates with other measures of disease severity, although its role in predicting
survival still needs to be addressed.
Pulse Wave Velocity: Theory, Applications, Methods, and Future DirectionsInsideScientific
Lee Stoner, PhD and Gabriel Zieff, MA present a complete, in-depth overview of their research involving Pulse Wave Velocity (PWV) in a variety of different applications and a deep dive into the methods they use to record high-quality, repeatable data.
Arguably, the “gold-standard” method for noninvasive assessment of cardiovascular disease risk is pulse wave velocity. The PWV is widely used in both epidemiological and physiological studies to assess arterial stiffness, a construct dependent on the functional and structural characteristics of a vessel. PWV is calculated by measuring the transit time of the arterial waveform between two points of a measured distance. The most widely studied path is between the carotid and femoral arteries, which represents the aorto-illiac pathway. Traditionally, these measurements are made using tonometers, which are highly sensitive pressure transducers. However, alternative approaches to tonometry are available, and pathways other than the aorta can be measured. These alternative approaches may be better suited for use with certain populations or study designs. The focus of the presentation is to assist the audience in identifying the correct research tool for their particular research paradigm. Specifically, these experts outline the theoretical principles underlying PWV, as well as the importance of this measure to both epidemiological and physiological studies. Subsequently, they highlight some of the different approaches for measuring PWV, including technical considerations. This is followed by discussion pertaining to the identification of the appropriate PWV measure for the specific study design and populations of interest. This includes consideration of internal and external validity. They end the session by providing some tips to facilitate high-quality PWV assessments.
Key Topics Include:
- Meaning and clinical importance of pulse wave velocity
- How to measure and interpret pulse wave velocity
- Considerations for internal- and external-validity
- Considerations for the measurement of pulse wave velocity of various study designs and populations
Pearls about NSAIDs and their usage in the managaement of chronic pain, considering safety profile of both selective cox-2 or non selective cox-2 inhibitors
The Role of Extracorporeal Photopheresis in Scleroderma is presented by
Jaehyuk Choi
Assistant Professor in the Department of Dermatology
Director of the Extracorporeal Photopherisis Unit
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...Dra. Mônica Lapa
Summary The recent development of treatment modalities for patients with
idiopathic pulmonary arterial hypertension has been based on the evaluation of
many different markers such as functional capacity, addressed by NYHA classification, six-minute walk test (6 MWT) and hemodynamic parameters. The aim of this
study was to evaluate the correlation of N-terminal fragment (NT-proBNP) with other
markers in IPAH and its potential for patient stratification.
We studied 42 IPAH patients consecutively evaluated through right heart
catheterization in the absence of any specific treatment for pulmonary hypertension. Blood samples, clinical evaluation and 6 MWF distance were collected at
baseline.
The levels of NT-proBNP showed a high correlation with hemodynamic
parameters, such as pulmonary vascular resistance (r ¼ 0:80, Po0.001). A significant
difference was found among patients with different functional classes, addressed by
NYHA classification (Po 0.02 for all groups comparison). The discriminant analysis
reinforced the ability of NT-proBNP to stratify patients according to NYHA functional
class. Compared to the other variables studied (hemodynamics and 6 MWT), NTproBNP had the lowest level of overlap in the stratification of IPAH patients.
We conclude that NT-proBNP differs among the different functional classes and
correlates with other measures of disease severity, although its role in predicting
survival still needs to be addressed.
Dra. Margaret Redfield. Congreso ACC 2013, Estados Unidos. RELAX: Inhibidor de la fosfodiesterasa-5 no mostró beneficio en la insuficiencia cardiaca con función ventricular preservada. Encuentre más presentaciones de este congreso en la página oficial de SOLACI: www.solaci.org/
The autonomic nervous system (ANS) controls all body functions. Dysregulation of this system may be responsible of bradycardia. The main objective of our study is to describe the autonomic profile of patients with bradycardia and to determine, through testing cardiovascular autonomic reflexes its involvement in the pathogenesis of idiopathic symptomatic bradycardia.
1. Flow-regulated vs Pressure-regulated shunts: A Prospective Analysis in Patients with Idiopathic Normal
Pressure Hydrocephalus
Phillip G. St. Louis MD; Jennifer Clements
Associates in Neurosurgery
Introduction
Guidelines for treatment of
Idiopathic Normal Pressure
(INPH)indicate ventriculoperitoneal
shunt placement as an effective
intervention. Current literature
comparing Differential Pressure
(DP) versus Flow Regulated (FR)
Valves for is lacking. This
prospective study evaluates one
year outcome data of 43 patients
randomized to either a DP or FR
valve.
Methods
All patients completed pre-operative
and post-operative evaluations to
assess hallmark indicators of INPH
such as magnetic gait (BERG
Balance Scale), cognitive
dysfunction (Neuropsychological
Assessment Battery [NAB]), and
ventriculomegaly (MRI/CT).
Patients who consented were then
randomized to a DP or FR valve.
Results
Baseline testing of the DP Group
(N=22) was NAB: 78.16 and BERG
34.2. Significant improvement was
demonstrated at 6 and 12 months
post-operatively with NAB: 86.5 and
87.75, and BERG 43.06,44.17
scores.
Baseline testing for the FR Group
(N=21) was NAB: 77.4 and BERG:
39. Improvement was noted at 6
and 12 months post operatively with
NAB: 86.25 and 89.17. There was a
slight decrease in the 6 and 12
month BERG: 47.2 and 46.11
scores. There were no shunt
infections. There was one subdural
hematoma in the FR Group requiring
surgical intervention in the
immediate post-operative period,
and 3 subdural hematomas in the
DP Group requiring 1 surgical
intervention. The number of follow
up appointments was slightly
increased in the DP Group, which
was primarily related to patients who
required shunt reprogramming.
Conclusions
Both shunt systems appear to be
effective in treatment of INPH.
Improvement was noted in both NAB
and BERG at 6 and 12 months post-
operatively when compared to
baseline. There was a distinct trend
of more striking improvement at 6
months in the FR Group. A
significantly higher incidence of
subdural hematomas was
demonstrated in the DP Group, most
of which were successfully managed
by shunt reprogramming.
Learning Objectives
Patients with Flow Regulated Valves
demonstrated a more striking
improvement at 6 months. Patients
with Differential Pressure Valves
experienced a larger incidence of
subdural hematomas, however most
of which were managed by shunt
reprogramming. Both groups
demonstrated overall improvement
when compared to baseline
References
1.Gangemi M, Maiuri F, Naddeo M, Godano U,
Mascari C, Broggi, et al: Endoscopic Third
Ventriculostomy in Idiopathic Normal Pressure
Hydrocephalus: An Italian Multicenter Study.
Neurosurg, 63: 62-69, 2008.
2.Hanlow P, Cinalli G, Vandertop P, Faber J,
Bogeskov L, Borgesen S, et al: Treatment of
hydrocephalus determined by the European
Orbis Sigma Valve II survey: a multicenter
prospective 5-year shunt survival study in
children and adults whom a flow-regulating
shunt was used. J Neurosurg 99: 52-57,
2003.3.Philippe D, Barat J, Duplessis E,
Leguerinel C, Gendrault P, and Keravel Y: Shunt
failure in adult hydrocephalus: Flow-controlled
shunt versus differential pressure shunts- A
cooperative study in 289 patients. Surg Neurol
43:333-339, 1995.4.Weiner H, Shlomo C,
Cohen H, Wisoff J: Current Treatment of Normal
-pressure Hydrocephalus: Comparison of Flow-
regulated and Differential-pressure Shunt
Valves. Neurosurg, 37(5):877-884,
1995.5.Zemack G, and Romner B: Adjustable
Valves in normal-pressure hydrocephalus: A
retrospective study of 218 patients. Neurosurg
51:1392-1402, 2002.6.Knutsson E, Lying-Tunell
U. Gait apraxia in normal-pressure
hydrocephalus: Patterns of movement and
muscle activation. Neurology 35, 135-
160.7.Bugalho P, Guimaraes J. Gait disturbance
in normal pressure hydrocephalus: A clinical
study. Parkinsonism and Related Disorders 13,
434-437, 2007.8.St Louis P, Horn G, Gorman P,
Johnson-Markve B, Wong B, Brustch B, Baez-
Torres S, Cole A, Tuppeny M, Johnson R.
Neurotransmission. 4, 1 2012. 9.Ravdin et al.
Features most responsive to tap test in normal
pressure hydrocephalus. Clin Neurol
Neurosurg.2008 May; 110 (5): 455-461.10.
Shprecher D, Schwalb J, Kurlan R. Normal
Pressure Hydrocephalus: Diagnosis and
Treatment. Curr Neurol Neurosci Rep. 2008
September; 8(5): 371-376.11.Merten T.
Neuropsychology of Normal Pressure
Hydrocephalus [in German]. Nervenarzt 70:496
-503, 1999. 12. Relkin N, Marmarou A, Klinge
P, Bergsneider M, Black P. Diagnosing
Idiopathic Normal-Pressure Hydrocephalus.
Neurosurgery. 57:3, 2005. 13. Vaneste JA.
Diagnosis and management of normal pressure
hydrocephalus. J Neurol. 2000;247:5-14. 14.
Donoghue D; Physiotherapy Research and Older
People (PROP) group, Stokes EK. (2009). How
much change is true change? The minimum
detectable change of the Berg Balance Scale in
elderly people. J Rehabil Med. 41(5):343-6. 15
Stern, R. A. & White T. (2003).
Neuropsychological Assessment Battery:
Administration, Scoring, and Interpretation
Manual,Psychological Assessment Resources,
Inc., Lutz, FL.16.Duff K. Evidence-based
indicators of neuropsychological change in the
individual patient: Relevant concepts and
methods; Kevin Duff; archives of clinical
neuropsychology; May 2012; 27(3): 248-261.
BERG Balance Scale
NAB